CompletedNCT05591703
Long-term outcomes after ear nerve stimulation for opioid relapse prevention
About this title
Read the official source — NCT05591703Observational studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Rancho Mirage and 2 more locationsSee all locations and recruitment
Study information
Study start dateStarted: November 21, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 32
- Sponsor
- Spark Biomedical, Inc.
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- Behavioural
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05591703
- Official title
Show the full official title
Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Rancho Mirage · Center City · Plymouth
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Spark Biomedical, Inc.
Who was this study for?
Listed age limits: 18 years to 65 years.
